Is ARDX Worth Buying in 2026?

Ardelyx, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Ardelyx, Inc. (ARDX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-5.94% over 10 days); RSI 19 — oversold; weak 1-year return of -30.5%; 3-month momentum negative (-34.8%); rising volume on a downtrend (distribution, 1.69x avg). Currently 51.7% off its 52-week high. Score: -7/7.

Ready to act on this? 📈 Trade on Webull

ARDX is trading below its 200-day MA ($5.99) — a key warning sign the longer-term trend is under pressure. An RSI of 18.9 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -30.5% compares to +20.4% for SPY (trailed the market by 50.9%). The current 51.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $6,952 today
vs. S&P 500 (SPY) — same period trailed market by 50.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($5.99)
Above 50-day MA ($5.21)
!RSI(14) neutral zone (30–70) — currently 18.9
Positive return (-30.5%)
!Within 10% of period high (−51.7%)
Period Range $4.06
$3.86 $8.40
RSI (14) 18.9
0 · OversoldOverbought · 100

Key Metrics

Price$4.06
Period Return-30.5%
Period High$8.40
Period Low$3.86
Drawdown−51.7%
MA-50$5.21
MA-200$5.99
RSI (14)18.9
Avg Volume (30d)4.1M
vs. SPYtrailed by 50.9%
Return Rank#953 of 1252

Trade ARDX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers